Skip to main content

Giant Cell Arteritis

  • Chapter
  • First Online:
Carotid Artery Disease

Abstract

Giant Cell Arteritis (GCA) is the most common systemic vasculitis. It targets large and medium caliber vessels and its classic symptoms result from a predilection for the cranial branches of the carotid arteries. It is a disorder of middle to older age and rarely affects individuals younger than 50. Diagnostic dilemmas frequently result from clinical presentations that can be highly variable and diagnostic tests that are often nonspecific or unreliable. The consequences of missing the diagnosis are high, with permanent vision loss occurring in 15–20% of patients. However, because it is a disease of older patients, often with medical comorbidities, standard treatment with systemic corticosteroids is far from benign in many cases. Accurate diagnosis and effective treatment require a high index of suspicion in nonspecific presentations, careful examination and diagnostic workup and, at times, tolerance for uncertainty in choosing the best clinical approach for each patient in which GCA is suspected.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 139.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. González-Gay MA, García-Porrúa C. Systemic vasculitis in adults in northwestern Spain, 1988-1997. Clinical and epidemiologic aspects. Medicine (Baltimore). 1999;78:292–308.

    Article  Google Scholar 

  2. Docken WP, Rosenbaum JT. Clinical manifestations of giant cell arteritis. In: Ramirez Curtis M, editor. UpToDate. Waltham, MA: UpToDate Inc. http://www.uptodate.com. Accessed on May 9, 2018.

  3. Hunder G. The early history of giant cell arteritis and polymyalgia Rheumatica: first descriptions to 1970. Mayo Clin Proc. 2006;81(8):1071–83.

    Article  Google Scholar 

  4. Hutchinson J. Diseases of the arteries. Arch Surg (London). 1889–90;1:323.

    Google Scholar 

  5. Horton BT, Magath TB, Brown GE. An Undescribed form of arteritis of the temporal vessels. Proc Staff Meet Mayo Clin. 1932;7:700–1.

    Google Scholar 

  6. Horton BT, Magath TB, Brown GE. Arteritis of the temporal vessels: previously undescribed form. Arch Int Med. 1934;53:400–9.

    Article  Google Scholar 

  7. Horton BT, Magath TB. Arteritis of the temporal vessels: report of 7 cases. Proc Staff Meet Mayo Clin. 1937;12:548–53.

    Google Scholar 

  8. Horton BT. The temporal arteritis story: discovery of a new entity, Horton’s disease. Boswell Hosp Proc. 1979;5:60–71.

    Google Scholar 

  9. Wagener HP, Hollenhorst RW. The ocular lesions of temporal arteritis. Am J Ophthalmol. 1958;45:617–30.

    Article  CAS  Google Scholar 

  10. Gonzalez-Gay MA, Vazquez-Rodriguez TR, Lopez-Diaz MJ, Miranda-Filloy JA, Gonzalez-Juanatey C, Martin J, Llorca J. Epidemiology of giant cell arteritis and polymyalgia rheumatica. Arthritis Rheum. 2009;61(10):1454–61.

    Article  Google Scholar 

  11. Smith CA, Fidler WJ, Pinals RS. The epidemiology of giant cell arteritis. Report of a ten-year study in Shelby County, Tennessee. Arthritis Rheum. 1983 Oct;26(10):1214–9.

    Article  CAS  Google Scholar 

  12. Ostberg G. An arteritis with special reference to Polymyalgia Arteritica. Acta Pathol Microbiol Scand Suppl. 1973;237(Suppl 237):1.

    Google Scholar 

  13. Smetana GW, Shmerling RH. Does this patient have temporal arteritis. JAMA. 2002;287(1):92–101.

    Article  Google Scholar 

  14. Solomon S, Cappa KG. The headache of temporal arteritis. J Am Geriatr Soc. 1987;35:163–5.

    Article  CAS  Google Scholar 

  15. Gonzalez-Gay MA, Barros S, Lopez-Diaz MJ, Garcia-Porrua C, Sanchez-Andrade A, Llorca J. Giant cell arteritis: disease patterns of clinical presentation in a series of 240 patients. Medicine (Baltimore). 2005;84(5):269–76.

    Article  Google Scholar 

  16. Salvarani C, Cantini F, Olivieri I, Barozzi L, Macchioni L, Niccoli L, Padula A, De Matteis M, Pavlica P. Proximal bursitis in active polymyalgia Rheumatica. Ann Intern Med. 1997;127(1):27–31.

    Article  CAS  Google Scholar 

  17. Arnow PM, Flaherty JP. Fever of unknown origin. Lancet. 1997;350(9077):575–80.

    Article  CAS  Google Scholar 

  18. Gonzalez-Gay MA, Lopez-Diaz MJ, Barros S, Garcia-Porrua C, Sanchez-Andrade A, Paz-Carreira J, Martin J, Llorca J. Giant cell arteritis: laboratory tests at the time of diagnosis in a series of 240 patients. Medicine (Baltimore). 2005;84(5):277–90.

    Article  Google Scholar 

  19. Salvarani C, Hunder GG. Giant cell arteritis with low erythrocyte sedimentation rate: frequency of occurence in a population-based study. Arthritis Rheum. 2001;45(2):140–5.

    Article  CAS  Google Scholar 

  20. Liozon E, Jauberteau-Marchan MO, Ly K, Loustaud-Ratti V, Soria P, Vidal E. Giant cell arteritis with a low erythrocyte sedimentation rate: comments on the article by Salvarani and Hunder. Arthritis Rheum. 2002;47(6):692–3.

    Article  Google Scholar 

  21. Kermani TA, Schmidt J, Crowson CS, Ytterberg SR, Hunder GG, Matteson EL, Warrington KJ. Utility of erythrocyte sedimentation rate and C-reactive protein for the diagnosis of giant cell arteritis. Semin Arthritis Rheum. 2012;41(6):866.. Epub 2011 Nov 25–71.

    Article  CAS  Google Scholar 

  22. Roche NE, Fulbright JW, Wagner AD, Hunder GG, Goronzy JJ, Weyand CM. Correlation of interleukin-6 production and disease activity in polymyalgia rheumatica and giant cell arteritis. Arthritis Rheum. 1993;36(9):1286–94.

    Article  CAS  Google Scholar 

  23. Weyand CM, Goronzy JJ. Medium- and large-vessel Vasculitis. N Engl J Med. 2003;349(2):160–9.

    Article  CAS  Google Scholar 

  24. Borchers AT, Gershwin ME. Giant cell arteritis: a review of the classification, pathophysiology, geoepidemiology and treatment. Autoimmun Rev. 2012;11(6–7):A544–54. https://doi.org/10.1016/j.autrev.2012.01.003.. Epub 2012 Jan 21

    Article  PubMed  Google Scholar 

  25. Salvarani C, Giannini C, Miller DV, Hunder G. Giant cell arteritis: involvement of intracranial arteries. Arthritis Rheum. 2006;55(6):985–9.

    Article  Google Scholar 

  26. Soriano A, Muratore F, Pipitone N, Boiardi L, Cimino L, Salvarani C. Visual loss and other cranial ischaemic complications in giant cell arteritis. Nat Rev Rheumatol. 2017;13(8):476–84. https://doi.org/10.1038/nrrheum.2017.98.. Epub 2017 Jul 6

    Article  PubMed  Google Scholar 

  27. Biousse V, Newman N. Ischemic optic neuropathies. N Engl J Med. 2015;372:2428–36.

    Article  CAS  Google Scholar 

  28. Rüegg S, Engelter S, Jeanneret C, Hetzel A, Probst A, Steck AJ, Lyrer P. Bilateral vertebral artery occlusion resulting from giant cell arteritis: report of 3 cases and review of the literature. Medicine (Baltimore). 2003;82(1):1–12.

    Article  Google Scholar 

  29. Gonzalez-Gay MA, Vazquez-Rodriguez TR, Gomez-Acebo I, Pego-Reigosa R, Lopez-Diaz MJ, Vazquez-Triñanes MC, Miranda-Filloy JA, Blanco R, Dierssen T, Gonzalez-Juanatey C, Llorca J. Strokes at time of disease diagnosis in a series of 287 patients with biopsy-proven giant cell arteritis. Medicine (Baltimore). 2009;88(4):227–35. https://doi.org/10.1097/MD.0b013e3181af4518.

    Article  Google Scholar 

  30. Buttgereit F, Dejaco C, Matteson EL, Dasgupta B. Polymyalgia Rheumatica and giant cell arteritis: a systematic review. JAMA. 2016;315(22):2442–58. https://doi.org/10.1001/jama.2016.5444.

    Article  CAS  PubMed  Google Scholar 

  31. Docken WP. Diagnosis of giant cell arteritis. Ramirez Curtis M, editor. UpToDate. Waltham, MA: UpToDate Inc. http://www.uptodate.com Accessed on May 9, 2018.

  32. Stone JH, Tuckwell K, Dimonaco S, Klearman M, Aringer M, Blockmans D, Brouwer E, Cid MC, Dasgupta B, Rech J, Salvarani C, Schett G, Schulze-Koops H, Spiera R, Unizony SH, Collinson N. Trial of tocilizumab in giant-cell arteritis. N Engl J Med. 2017;377(4):317–28.

    Article  CAS  Google Scholar 

  33. Hayreh SS, Zimmerman B. Visual deterioration in giant cell arteritis patients while on high doses of corticosteroid therapy. Ophthalmology. 2003;110(6):1204–15.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Gaines, N., Liebeskind, D.S. (2020). Giant Cell Arteritis. In: Park, M., Kalani, M., de Havenon, A., McNally, J. (eds) Carotid Artery Disease. Springer, Cham. https://doi.org/10.1007/978-3-030-41138-1_15

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-41138-1_15

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-41137-4

  • Online ISBN: 978-3-030-41138-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics